NCT05503225View on ClinicalTrials.gov

Colchicine Use in Intracranial Atherosclerotic Disease

PHASE2RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

November 28, 2022

Primary Completion Date

September 30, 2025

Study Completion Date

May 31, 2026

Conditions
ICAD - Intracranial Atherosclerotic Disease
Interventions
DRUG

Colchicine 0.5 MG

0.5mg Orally Taken Colchicine

Trial Locations (1)

Unknown

RECRUITING

Chinese University of Hong Kong, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER